Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts

Environmental Microbiology

Volumn 12, Issue 6, 2010, Pages 1643-1658

  Rau, Martin Holm ^a   Hansen, Susse Kirkelund ^a   Johansen, Helle Krogh ^b   Thomsen, Line Elnif ^c   Workman, Christopher T ^a   Nielsen, Kristian Fog ^a   Jelsbak, Lars ^a   Høiby, Niels ^b   Yang, Lei ^a   Molin, Søren ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; GLUCURONIC ACID; HEXURONIC ACID;

ADAPTATION; ANIMAL; ARTICLE; CHILD; CYSTIC FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MICROARRAY ANALYSIS; MICROBIOLOGY; MOLECULAR GENETICS; MUTATION; PATHOGENICITY; PHENOTYPE; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY SYSTEM; VIRULENCE;

ADAPTATION, PHYSIOLOGICAL; ALGINATES; ANIMALS; CHILD; CYSTIC FIBROSIS; GENE EXPRESSION REGULATION, BACTERIAL; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; MICROARRAY ANALYSIS; MOLECULAR SEQUENCE DATA; MUTATION; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY SYSTEM; VIRULENCE;

EID: 77954645140     PISSN: 14622912     EISSN: 14622920     Source Type: Journal    
DOI: 10.1111/j.1462-2920.2010.02211.x     Document Type: Article

References (72)

1. Aguilar, J.A., Zavala, A.N., Diaz-Perez, C., Cervantes, C., Diaz-Perez, A.L., and Campos-Garcia, J. (2006) The atu and liu clusters are involved in the catabolic pathways for acyclic monoterpenes and leucine in Pseudomonas aeruginosa. Appl Environ Microbiol 72: 2070-2079.
2. Aires, J.R., Kohler, T., Nikaido, H., and Plesiat, P. (1999) Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother 43: 2624-2628.
3. Aspedon, A., Palmer, K., and Whiteley, M. (2006) Microarray analysis of the osmotic stress response in Pseudomonas aeruginosa. J Bacteriol 188: 2721-2725.
4. Bagge, N., Ciofu, O., Hentzer, M., Campbell, J.I., Givskov, M., and Hoiby, N. (2002) Constitutive high expression of chromosomal beta-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD. Antimicrob Agents Chemother 46: 3406-3411.
5. Bantinaki, E., Kassen, R., Knight, C.G., Robinson, Z., Spiers, A.J., and Rainey, P.B. (2007) Adaptive divergence in experimental populations of Pseudomonas fluorescens. III. Mutational origins of wrinkly spreader diversity. Genet 176: 441-453.
6. Barth, A.L., and Pitt, T.L. (1996) The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J Med Microbiol 45: 110-119.
7. Boucher, J.C., Yu, H., Mudd, M.H., and Deretic, V. (1997) Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect Immun 65: 3838-3846.
8. Bragonzi, A., Paroni, M., Nonis, A., Cramer, N., Montanari, S., Rejman, J., et al. (2009) Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am J Respir Crit Care Med 180: 138-145.
9. Burns, J.L., Gibson, R.L., McNamara, S., Yim, D., Emerson, J., Rosenfeld, M., et al. (2001) Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 183: 444-452.
10. Cabral, D.A., Loh, B.A., and Speert, D.P. (1987) Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages. Pediatr Res 22: 429-431.
11. Carterson, A.J., Morici, L.A., Jackson, D.W., Frisk, A., Lizewski, S.E., Jupiter, R., et al. (2004) The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa. J Bacteriol 186: 6837-6844.
12. Choi, K.H., and Schweizer, H.P. (2005) An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutants. BMC Microbiol 5: 30.
13. Ciofu, O., Fussing, V., Bagge, N., Koch, C., and Hoiby, N. (2001) Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, beta-lactamase activity and RiboPrinting. J Antimicrob Chemother 48: 391-396.
14. Ciofu, O., Lee, B., Johannesson, M., Hermansen, N.O., Meyer, P., and Hoiby, N. (2008) Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants. Microbiology 154: 103-113.
15. Elena, S.F., and Lenski, R.E. (2003) Evolution experiments with microorganisms: the dynamics and genetic bases of adaptation. Nat Rev Genet 4: 457-469.
16. Firoved, A.M., and Deretic, V. (2003) Microarray analysis of global gene expression in mucoid Pseudomonas aeruginosa. J Bacteriol 185: 1071-1081.
17. Goldberg, J.B., and Pier, G.B. (1996) Pseudomonas aeruginosa lipopolysaccharides and pathogenesis. Trends Microbiol 4: 490-494.
18. Govan, J.R., and Deretic, V. (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60: 539-574.
19. Gutierrez, C., and Devedjian, J.C. (1991) Osmotic induction of gene osmC expression in Escherichia coli K12. J Mol Biol 220: 959-973.
20. Gutierrez, C., Gordia, S., and Bonnassie, S. (1995) Characterization of the osmotically inducible gene osmE of Escherichia coli K-12. Mol Microbiol 16: 553-563.
21. Hancock, R.E. (1997) The bacterial outer membrane as a drug barrier. Trends Microbiol 5: 37-42.
22. Hancock, R.E., and Speert, D.P. (2000) Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment. Drug Resist Updat 3: 247-255.
23. Hansen, C.R., Pressler, T., and Hoiby, N. (2008) Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J Cyst Fibros 7: 523-530.
24. Hansen, S.K., Haagensen, J.A., Gjermansen, M., Jorgensen, T.M., Tolker-Nielsen, T., and Molin, S. (2007) Characterization of a Pseudomonas putida rough variant evolved in a mixed-species biofilm with Acinetobacter sp. strain C6. J Bacteriol 189: 4932-4943.
25. Hoang, T.T., Karkhoff-Schweizer, R.R., Kutchma, A.J., and Schweizer, H.P. (1998) A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212: 77-86.
26. Høiby, N., and Frederiksen, B. (2000) Microbiology of cystic fibrosis. In Cystic Fibrosis, 2nd edn. Hodson, M.E., and Geddes, D.M. (eds). London, UK: Hodder Arnold, pp. 83-107.
27. Høiby, N., Krogh Johansen, H., Moser, C., Song, Z., Ciofu, O., and Kharazmi, A. (2001) Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect 3: 23-35.
28. Høiby, N., Frederiksen, B., and Pressler, T. (2005) Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros 4 (Suppl. 2): 49-54.
29. Holloway, B.W., and Morgan, A.F. (1986) Genome organization in Pseudomonas. Annu Rev Microbiol 40: 79-105.
30. Islam, S., Oh, H., Jalal, S., Karpati, F., Ciofu, O., Hoiby, N., and Wretlind, B. (2009) Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Clin Microbiol Infect 15: 60-66.
31. Jalal, S., Ciofu, O., Hoiby, N., Gotoh, N., and Wretlind, B. (2000) Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 44: 710-712.
32. Jeannot, K., Elsen, S., Kohler, T., Attree, I., van Delden, C., and Plesiat, P. (2008) Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump. Antimicrob Agents Chemother 52: 2455-2462.
33. Jelsbak, L., Johansen, H.K., Frost, A.L., Thogersen, R., Thomsen, L.E., Ciofu, O., et al. (2007) Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun 75: 2214-2224.
34. Johansen, H.K., and Hoiby, N. (1992) Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 47: 109-111.
35. Kessler, B., de Lorenzo, V., and Timmis, K.N. (1992) A general system to integrate lacZ fusions into the chromosomes of gram-negative eubacteria: regulation of the Pm promoter of the TOL plasmid studied with all controlling elements in monocopy. Mol Gen Genet 233: 293-301.
36. Koch, A.K., Kappeli, O., Fiechter, A., and Reiser, J. (1991) Hydrocarbon assimilation and biosurfactant production in Pseudomonas aeruginosa mutants. J Bacteriol 173: 4212-4219.
37. Koch, C. (2002) Early infection and progression of cystic fibrosis lung disease. Pediatr Pulmonol 34: 232-236
38. Koch, C., and Hoiby, N. (1993) Pathogenesis of cystic fibrosis. Lancet 341: 1065-1069.
39. Kolter, R. (1999) Growth in studying the cessation of growth. J Bacteriol 181: 697-699.
40. Lee, B., Haagensen, J.A., Ciofu, O., Andersen, J.B., Hoiby, N., and Molin, S. (2005) Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J Clin Microbiol 43: 5247-5255.
41. Linares, J.F., Lopez, J.A., Camafeita, E., Albar, J.P., Rojo, F., and Martinez, J.L. (2005) Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. J Bacteriol 187: 1384-1391.
42. Lizewski, S.E., Schurr, J.R., Jackson, D.W., Frisk, A., Carterson, A.J., and Schurr, M.J. (2004) Identification of AlgRregulated genes in Pseudomonas aeruginosa by use of microarray analysis. J Bacteriol 186: 5672-5684.
43. de Lorenzo, V., and Timmis, K.N. (1994) Analysis and construction of stable phenotypes in gram-negative bacteria with Tn5- and Tn10-derived minitransposons. Methods Enzymol 235: 386-405.
44. Mahenthiralingam, E., Campbell, M.E., and Speert, D.P. (1994) Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 62: 596-605.
45. Martin, D.W., Schurr, M.J., Mudd, M.H., Govan, J.R., Holloway, B.W., and Deretic, V. (1993) Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci USA 90: 8377-8381.
46. Martin, R.R., Marshall, V.D., Sokatch, J.R., and Unger, L. (1973) Common enzymes of branched-chain amino acid catabolism in Pseudomonas putida. J Bacteriol 115: 198-204.
47. Mathee, K., Ciofu, O., Sternberg, C., Lindum, P.W., Campbell, J.I., Jensen, P., et al. (1999) Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 145: 1349-1357.
48. Morici, L.A., Carterson, A.J., Wagner, V.E., Frisk, A., Schurr, J.R., Honer zu Bentrup, K., et al. (2007) Pseudomonas aeruginosa AlgR represses the Rhl quorum-sensing system in a biofilm-specific manner. J Bacteriol 189: 7752-7764.
49. Palmer, K.L., Aye, L.M., and Whiteley, M. (2007) Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol 189: 8079-8087.
50. Pamp, S.J., and Tolker-Nielsen, T. (2007) Multiple roles of biosurfactants in structural biofilm development by Pseudomonas aeruginosa. J Bacteriol 189: 2531-2539.
51. Pedersen, S.S. (1992) Lung infection with alginateproducing, mucoid Pseudomonas aeruginosa in cystic fibrosis. APMIS Suppl 28: 1-79.
52. Rahme, L.G., Stevens, E.J., Wolfort, S.F., Shao, J., Tompkins, R.G., and Ausubel, F.M. (1995) Common virulence factors for bacterial pathogenicity in plants and animals. Science 268: 1899-1902.
53. Rhodius, V.A., Suh, W.C., Nonaka, G., West, J., and Gross, C.A. (2006) Conserved and variable functions of the sigmaE stress response in related genomes. Plos Biol 4: e2.
54. Rohwer, F., and Edwards, R. (2002) The Phage Proteomic Tree: a genome-based taxonomy for phage. J Bacteriol 184: 4529-4535.
55. Rowen, D.W., and Deretic, V. (2000) Membrane-to-cytosol redistribution of ECF sigma factor AlgU and conversion to mucoidy in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Mol Microbiol 36: 314-327.
56. Sanchez, P., Linares, J.F., Ruiz-Diez, B., Campanario, E., Navas, A., Baquero, F., and Martinez, J.L. (2002) Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants. J Antimicrob Chemother 50: 657-664.
57. Schnabel, H., and Schnabel, R. (1990) An organ-specific differentiation gene, pha-1, from Caenorhabditis elegans. Science 250: 686-688.
58. Smith, E.E., Buckley, D.G., Wu, Z., Saenphimmachak, C., Hoffman, L.R., D'Argenio, D.A., et al. (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA 103: 8487-8492.
59. Spencer, R.C. (1996) An 8 year Microbe Base survey of the epidemiology, frequency and antibiotic susceptibility of Pseudomonas aeruginosa hospital isolates in the United Kingdom. J Antimicrob Chemother 37: 295-301.
60. Stover, C.K., Pham, X.Q., Erwin, A.L., Mizoguchi, S.D., Warrener, P., Hickey, M.J., et al. (2000) Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406: 959-964.
61. Tan, M.W., Rahme, L.G., Sternberg, J.A., Tompkins, R.G., and Ausubel, F.M. (1999) Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors. Proc Natl Acad Sci USA 96: 2408-2413.
62. Tart, A.H., Blanks, M.J., and Wozniak, D.J. (2006) The AlgTdependent transcriptional regulator AmrZ (AlgZ) inhibits flagellum biosynthesis in mucoid, nonmotile Pseudomonas aeruginosa cystic fibrosis isolates. J Bacteriol 188: 6483-6489.
63. Terry, J.M., Pina, S.E., and Mattingly, S.J. (1991) Environmental conditions which influence mucoid conversion Pseudomonas aeruginosa PAO1. Infect Immun 59: 471-477.
64. Thomsen, L.E., Slutz, S.S., Tan, M.W., and Ingmer, H. (2006) Caenorhabditis elegans is a model host for Listeria monocytogenes. Appl Environ Microbiol 72: 1700-1701.
65. Wiehlmann, L., Wagner, G., Cramer, N., Siebert, B., Gudowius, P., Morales, G., et al. (2007) Population structure of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 104: 8101-8106.
66. Wolfgang, M.C., Kulasekara, B.R., Liang, X., Boyd, D., Wu, K., Yang, Q., et al. (2003) Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 100: 8484-8489.
67. Wood, L.F., and Ohman, D.E. (2009) Use of cell wall stress to characterize sigma 22 (AlgT/U) activation by regulated proteolysis and its regulon in Pseudomonas aeruginosa. Mol Microbiol 72: 183-201.
68. Wu, W., Badrane, H., Arora, S., Baker, H.V., and Jin, S. (2004) MucA-mediated coordination of type III secretion and alginate synthesis in Pseudomonas aeruginosa. J Bacteriol 186: 7575-7585.
69. Wylie, J.L., and Worobec, E.A. (1995) The OprB porin plays a central role in carbohydrate uptake in Pseudomonas aeruginosa. J Bacteriol 177: 3021-3026.
70. Yang, L., Haagensen, J.A., Jelsbak, L., Johansen, H.K., Sternberg, C., Hoiby, N., and Molin, S. (2008) In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J Bacteriol 190: 2767-2776.
71. Zinser, E.R., and Kolter, R. (1999) Mutations enhancing amino acid catabolism confer a growth advantage in stationary phase. J Bacteriol 181: 5800-5807.
72. Zinser, E.R., and Kolter, R. (1999) Mutations enhancing amino acid catabolism confer a growth advantage in stationary phase. J Bacteriol 181: 5800-5807.